Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
(+)control: wild type gB, ()control fusion dead construct gB(aa1-852)
After open-label ZEPBOUND treatment, randomized patients (n=670) had an average body weight loss of 20.9% (Week 0 to Week 36)
Get in touch today to learn more
To provide adequate time and support for these issues, consider offering weight-prioritized visits
In Aurora, tirzepatide injections combined with expert guidance offer a promising path to meaningful and sustainable weight loss, enabling patients to reclaim control of their health
US$ 23.45
US$ 29.84
US$ 27.54
US$ 27.02
